Exam 4- Peripheral Nervous System Flashcards
Guillain-Barre´ Syndrome
- Acute onset
- Monophasic immune-mediated disorder of the peripheral nervous system
- Demyelination of peripheral nerves
- Result of immune-mediated pathologic processes
-Symptoms:
Initial muscle weakness and pain
Ascending paralysis
Autonomic dysfunction
-Incidence: 1-2 cases per 100,000
-Variants
Acute inflammatory demyelinating polyradicularneuropathy (AIDP) most common in the US
Guillain-Barre´ Syndrome: Etiology
- Immune mediated response:IgG antibodies
- Viral infections
- Bacterial infection-have you been sick with any type of infection?
- Vaccines
- Lymphoma
- Surgery
- Trauma
GB Patho
- Segmental demyelination process of the peripheral nerves
- T cells migrate to the peripheral nerves: Edema & inflammation
-Macrophages:
Break down myelin
Inflammation
axonal damage
Stages of Guillain-Barre: Initial
- 1-4 weeks
- onset til no new symptoms present
Stages of Guillain-Barre: Plateau
- several days to 2 weeks
- no deterioration and no improvement
Stages of Guillain-Barre: Recovery
- 4-6 months and up to 2 years
- remyelination and return of muscle strength
- Recovery much faster in young adults
GB Signs & symptoms
-Motor weakness, parathesias
-Cranial nerve dysfunction:
Oculomotor, facial, glossopharyngeal, vagal, spinal accessory, hypoglossal
-Autonomic dysfunction:
BP fluctuation
dysrhythmias
- Motor loss:
- Symmetric, bilateral, ascending(eventually have the inability to take a deep breath)*
- Measure tidal volume, chest rise (RR) q4h*
-Respiratory function:
Inspiratory force, tidal volume
GB: Diagnosis
-CSF analysis:
Elevated CSF proteins with normal cell counts (wbc & rbc okay)
-Nerve conduction studies:
Electromyeography (EMG)
Nerve conduction velocity
GB: Management
-Plasmapheresis:
Exchanges occur ~ three to four treatments, 1 to 2 days apart
IV access in hospital
Need intubation
-Intravenous Immune globulin (IVIG):
Daily dose based on body weight for 5 consecutive days
Plasmapheresis
- Removes circulating antibodies assumed to cause disease
- Plasma selectively separated from whole blood; blood cells returned to patient without plasma
- Plasma usually replaces itself, or patient is transfused with albumin
GB: Collaborative management
-Survey for complications
-Acute dysautonomia
-HR, BP
-Respiratory care
-Atelectasis, VAP,
pneumothorax, ARDS
-Skin & musculoskeletal - support
-Decubiti, ROM
-Gastrointestinal
-Ileus
- Initiating rehab in the ICU
- Early mobility
- Nutritional support
- enteral - Emotional support
- Due to sudden paralysis
- Patient education
GB: Plan of Care
-Diagnostic testing
-Priority nursing care Respiratory care Pain management Communication and emotional (altenate methods, specialized call button) Nutritional
- Involvement of family, other team members
- Education
- Medical treatments—plasmapheresis
Myasthenia Gravis
- An acquired autoimmune disease characterized by muscle weakness
- Caused by antibodies that interfere with the transmission of acetylcholine at the neruromuscular junction
Types of MG
Ocular & Generalized
MG Risk factors
- Coexisting autoimmune disorder
- Hyperplasia of the thymus gland